Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)

NCT: NCT07227805 · RECRUITING

NCT IDNCT07227805
StatusRECRUITING
Start Date2026-07-19
Completion2027-03-17
SponsorMedtronic MiniMed, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This study will demonstrate the safety and performance of the Novel Medtronic Experimental Automated Insulin Delivery system named MiniMed™ NMX8 system in people living with insulin-requiring diabetes in comparison with the MiniMed™ 780G system.

Frequently Asked Questions

What is Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)?

Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS) is a clinical trial registered under NCT07227805. Current status: RECRUITING.

What is the status of NCT07227805?

The current status of NCT07227805 (Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)) is: RECRUITING.

When did Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS) start?

Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS) started on 2026-07-19.

Related Devices

PMA P250012Sensor, Glucose, Invasive, Component of automated insulin delivery systemMedtronic Minimed, Inc. K251032MiniMed 780G insulin pumpMedtronic Minimed, Inc. K253470MiniMed 780G Insulin Pump (MMT-1884); MiniMed 780G Insulin Pump Kit (MMT-1894)Medtronic Minimed, Inc. PMA P150001Automated insulin dosing , threshold suspendMedtronic Minimed PMA P160017Automated insulin dosing device system, single hormonal controlMedtronic Minimed, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑